Cited by 2,194Pancreatic and Hepatic Oncology ResearchGene expression and cancer classificationBreast Cancer Treatment Studies

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Open access

Moffitt, Richard A, Marayati, Raoud, Flate, Elizabeth L, Volmar, Keith E, Loeza, S Gabriela Herrera, Hoadley, Katherine A, Rashid, Naim U, Williams, Lindsay A, Eaton, Samuel C, Chung, Alexander H, Smyla, Jadwiga K, Anderson, Judy M, Kim, Hong Jin, Bentrem, David J, Talamonti, Mark S, Iacobuzio-Donahue, Christine A, Hollingsworth, Michael A, Yeh, Jen Jen·2015·Nature Genetics

DOI 10.1038/ng.3398PMC PMC4912058

Open this paper in CoChat — free account

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival rate of 4%. A key hallmark of PDAC is extensive stromal involvement, which makes capturing precise tumor-specific molecular information difficult. Here we have overcome this problem by applying blind source separation to a diverse collection of PDAC gene expression microarray data, including data from primary tumor, metastatic and normal samples. By digitally separating tumor, stromal and normal gene expression, we have identified and validated two tumor subtypes, including a 'basal-like' subtype that has worse outcome and is molecularly similar to basal tumors in bladder and breast cancers. Furthermore, we define 'normal' and 'activated' stromal subtypes, which are independently prognostic. Our results provide new insights into the molecular composition of PDAC, which may be used to tailor therapies or provide decision support in a clinical setting where the choice and timing of therapies are critical.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/ng.3398

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,145
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778
Self-citation
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
The Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S. C. Y., Voduc, D. K., Vickery, T. L., Davies, S. R., Fauron, C. M. ‐., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,818
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation

Show all 63 references

Sorted by citations

Items 901–1,000 of 1,002

An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
Pan, C., Otsuka, Y., Sridharan, B., Woo, M., Leiton, C. V., Babu, S., Gonçalves, M. T., Kawalerski, R. R., Bai, J. D. K., Chang, D. K.-F., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12743 · Cited by 16
Modifications of pancreatic diffusion MRI by tissue characteristics: what are we weighting for?
Nissan, N. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3728 · Cited by 16
A tangled tale of molecular subtypes in pancreatic cancer
Singh, S. K., Hasselluhn, M. C., & Neeße, A. (2019) · Gut · doi:10.1136/gutjnl-2018-318086 · Cited by 16
Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma
Roy, S., Singh, A. P., & Gupta, D. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06000 · Cited by 17
Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom‐up approach
Hilmi, M., Delecourt, F., Raffenne, J., Bourega, T. A., Dusetti, N., Iovanna, J., Blum, Y., Richard, M., Neuzillet, C., Couvelard, A., et al. (2025) · The Journal of Pathology · doi:10.1002/path.6398 · Cited by 15
Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma
Smith, S. J., Meng, F., Lingeman, R. G., Li, C. M., Li, M., Boneh, G., Seppälä, T. T., Phan, T. X., Li, H., Burkhart, R. A., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.02.038 · Cited by 16
Multi-omics integration and machine learning uncover molecular basal-like subtype of pancreatic cancer and implicate A2ML1 in promoting tumor epithelial-mesenchymal transition
Ge, J., Cai, J., Zhang, G., Li, D., & Tao, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06711-z · Cited by 16
Identification immunophenotyping of lung adenocarcinomas based on the tumor microenvironment
Tan, Q., Huang, Y., Deng, K., Lu, M., Wang, L., Rong, Z., Zhao, W., Li, S., Xu, Z., Fan, L., et al. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29675 · Cited by 15
Refining the Molecular Framework for Pancreatic Cancer with Single-cell and Spatial Technologies
Guo, J. A., Hoffman, H. I., Weekes, C. D., Zheng, L., Ting, D. T., & Hwang, W. L. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4712 · Cited by 14
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
Aughton, K., Elander, N. O., Evans, A., Jackson, R., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G., Valle, J. W., et al. (2021) · Cancers · doi:10.3390/cancers13225758 · Cited by 16
Loss of FGFR4 promotes the malignant phenotype of PDAC
D’Agosto, S. L., Pezzini, F., Veghini, L., Delfino, P., Fiorini, C., Tane, G. D. T., Curatolo, A. D., Vicentini, C., Ferrari, G., Pasini, D., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02432-5 · Cited by 15
Cytotoxic Chemotherapy in Advanced Pancreatic Cancer
Rehman, M. U., Khaled, A., & Noel, M. S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.07.006 · Cited by 15
The Microbiome in PDAC—Vantage Point for Future Therapies?
Pfisterer, N., Lingens, C., Heuer, C., Dang, L., Neeße, A., & Ammer‐Herrmenau, C. (2022) · Cancers · doi:10.3390/cancers14235974 · Cited by 15
CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
Thalji, S. Z., Kamgar, M., George, B., Aldakkak, M., Christians, K. K., Clarke, C. N., Erickson, B. A., Hall, W. A., Tolat, P. P., Smith, Z. L., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-022-13055-1 · Cited by 15
Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion
Bort, E. T., Joseph, M. D., Wang, Q., Carter, E. P., Roth, N. J., Gibson, J., Samadi, A., Kocher, H. M., Simoncelli, S., McCormick, P. J., et al. (2023) · eLife · doi:10.7554/elife.86971 · Cited by 15
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases
Kartha, N., Gianopulos, J. E., Schrank, Z., Cavender, S. M., Dobersch, S., Kynnap, B. D., Wallace-Povirk, A., Wladyka, C. L., Santana, J. F., Kim, J. C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn9674 · Cited by 15
The role of molecular testing in pancreatic cancer
Zhen, D. B., Safyan, R. A., Konick, E. Q., Nguyen, R., Pritchard, C. C., & Chiorean, E. G. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231171456 · Cited by 16
Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
Freed, I. M., Kasi, A., Fateru, O., Hu, M., Gonzalez, P., Weatherington, N., Pathak, H. B., Hyter, S. D., Sun, W., Al-Rajabi, R. M. T., et al. (2023) · Cells · doi:10.3390/cells12182266 · Cited by 16
Emerging Prognostic and Predictive Factors in Pancreatic Cancer
Karamitopoulou, E. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100328 · Cited by 16
Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer
Guo, Y., Wang, R., Shi, J., Yang, C., Ma, P., Min, J., Zhao, T., Hua, L., Song, Y., Li, J., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007466 · Cited by 15
Spatial immune composition of tumor microenvironment in patients with pancreatic cancer
Zwart, E. S., van Ee, T., Affandi, A. J., Boyd, L. N. C., Rodríguez, E., den Haan, J. M. M., Sarasqueta, A. F., van Grieken, N. C. T., Meijer, L. L., van Kooyk, Y., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03573-6 · Cited by 15
Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic Propensities
Philipp, L.-M., Yesilyurt, U.-U., Surrow, A., Künstner, A., Mehdorn, A., Hauser, C., Gundlach, J.-P., Will, O., Hoffmann, P., Stahmer, L., et al. (2024) · Cancers · doi:10.3390/cancers16040686 · Cited by 14
Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions
Wolfe, A. R., Cui, T., Baie, S., Corrales-Guerrero, S., Webb, A., Castro-Aceituno, V., Shyu, D.-L., Karasinska, J. M., Topham, J. T., Renouf, D. J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj3551 · Cited by 16
Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma
Shibayama, T., Hayashi, A., Masao, T., Kitahama, K., Ho, Y.-J., Kato, K., Yamada, T., Kawamoto, S., Kambayashi, K., Ochiai, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65900-w · Cited by 15
Self-citation
A Deep Learning Approach for the Identification of the Molecular Subtypes of Pancreatic Ductal Adenocarcinoma Based on Whole Slide Pathology Images
Ahmadvand, P., Farahani, H., Farnell, D., Darbandsari, A., Topham, J. T., Karasinska, J. M., Nelson, J., Naso, J. R., Jones, S. J. M., Renouf, D. J., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.08.006 · Cited by 17
Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer
Liu, L., Huang, H., Cheng, B., Xie, H., Wang, P., Cui, H., Liang, J., Cao, M., Yang, Y., Chen, W., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111612 · Cited by 15
Experimental pancreatic cancer develops in soft pancreas: novel leads for an individualized diagnosis by ultrafast elasticity imaging
Therville, N., Arcucci, S., Vertut, A., Ramos‐Delgado, F., Mota, D. F. D., Dufresne, M., Basset, C., & Guillermet‐Guibert, J. (2019) · Theranostics · doi:10.7150/thno.34066 · Cited by 15
A Network-Based Approach for Identification of Subtype-Specific Master Regulators in Pancreatic Ductal Adenocarcinoma
Zhang, Y., Zhu, L., & Wang, X. (2020) · Genes · doi:10.3390/genes11020155 · Cited by 15
Reviving the Autopsy for Modern Cancer Evolution Research
Robb, T. J., Tse, R. D., & Blenkiron, C. (2021) · Cancers · doi:10.3390/cancers13030409 · Cited by 19
Pancreatic ductal adenocarcinoma in the era of precision medicine
Zheng-Lin, B., & O'Reilly, E. M. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.01.005 · Cited by 16
Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
Gil, Y. R., Sánchez, P. J., Velasco, R. M., García, A. G., & Lobo, V. J. S.-A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042077 · Cited by 18
Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma
Cleary, J. M., Wolpin, B. M., Dougan, S. K., Raghavan, S., Singh, H., Huffman, B. M., Sethi, N. S., Nowak, J. A., Shapiro, G. I., Aguirre, A. J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1367 · Cited by 16
Models of pancreatic ductal adenocarcinoma
Dennaoui, R., Shrestha, H., & Wagner, K. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09989-9 · Cited by 19
Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits
Li, M., Yuan, J., Guan, X., Ma, N., & Liu, M. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00246-x · Cited by 16
Multi-omics landscape and clinical significance of a SMAD4 -driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer
Wang, L., Liu, Z., Zhu, R., Liang, R., Wang, W., Li, J., Zhang, Y., Guo, C., Han, X., & Sun, Y. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.02.031 · Cited by 15
Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells
Alfarano, G., Audano, M., Chiaro, P. D., Balestrieri, C., Milan, M., Polletti, S., Spaggiari, P., Zerbi, A., Diaferia, G. R., Mitro, N., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325811 · Cited by 17
Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for Thought
Agostini, A., Orlacchio, A., Carbone, C., & Guerriero, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876291 · Cited by 14
Combined microRNA and mRNA microfluidic TaqMan array cards for the diagnosis of malignancy of multiple types of pancreatico-biliary tumors in fine-needle aspiration material
Gress, T. M., Lausser, L. M., Schirra, L.-R., Ortmüller, L., Diels, R., Kong, B., Michalski, C. W., Hackert, T., Strobel, O., Giese, N. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22601 · Cited by 15
Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies
Yamamoto, K. N., Nakamura, A., Liu, L. L., Stein, S., Tramontano, A. C., Kartoun, U., Shimizu, T., Inoue, Y. H., Asakuma, M., Haeno, H., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215409 · Cited by 15
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer
Ding, L.-Y., Hou, Y., Kuo, I., Hsu, T.-Y., Tsai, T.-C., Chang, H.-W., Hsu, W.-Y., Tsao, C.-C., Tian, C.-C., Wang, P., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00878-6 · Cited by 14
Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis
Li, J., Zeng, Z., Jiang, X., Zhang, N., Gao, Y., Luo, Y., Sun, W., Li, S., Ren, J., Gong, Y. Q., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75541-4 · Cited by 16
Pancreatic cancer: failures and hopes—a review of new promising treatment approaches
Cereda, V., & D'Andrea, M. R. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002299 · Cited by 16
Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis
Gong, R., Chen, Y., Chang, D. K.-F., Zhang, H., Liu, Z., & Yu, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1555036 · Cited by 14
Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective
Perales-Patón, J., Piñeiro-Yáñez, E., Tejero, H., Lopez-Casas, P. P., Hidalgo, M. M., Goméz-López, G., & Al‐Shahrour, F. (2017) · Public Health Genomics · doi:10.1159/000479812 · Cited by 13
Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges
Hakuno, S. K., Michiels, E., Kuhlemaijer, E. B., Rooman, I., Hawinkels, L. J. A. C., & Slingerland, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063147 · Cited by 15
Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for Pancreatic Adenocarcinoma
Xiong, F., Guo, T., Wang, X., Wu, G., Liu, W., Wang, Q., Wang, B., & Chen, Y. (2022) · Disease Markers · doi:10.1155/2022/8159537 · Cited by 16
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
Kawakubo, K., Castillo, C. F.-D., & Liss, A. S. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01915-2 · Cited by 17
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma
Heid, I., Münch, C., Karakaya, S., Lueong, S., Winkelkotte, A. M., Liffers, S. T., Godfrey, L., Cheung, P. F., Savvatakis, K., Topping, G. J., et al. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00298-5 · Cited by 14
Cross-Dataset Single-Cell Analysis Identifies Temporal Alterations in Cell Populations of Primary Pancreatic Tumor and Liver Metastasis
Yang, D., Moniruzzaman, R., Wang, H., Wang, H., & Chen, Y. (2023) · Cancers · doi:10.3390/cancers15082396 · Cited by 13
Tumor Microenvironment Role in Pancreatic Cancer Stem Cells
Galindo-Vega, A., Maldonado, V., Mitre-Aguilar, I. B., & Meléndez-Zajgla, J. (2023) · Cells · doi:10.3390/cells12121560 · Cited by 14
A Novel HOXA10 -Associated 5-Gene–Based Prognostic Signature for Stratification of Short-term Survivors of Pancreatic Ductal Adenocarcinoma
Kisling, S. G., Atri, P., Shah, A., Cox, J. L., Sharma, S., Smith, L. M., Ghersi, D., & Batra, S. K. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0825 · Cited by 14
Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma
Wang, X., Yang, J., Ren, B., Yang, G., Liu, X., Xiao, R., Ren, J., Zhou, F., You, L., & Zhao, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101143 · Cited by 14
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation
Godfrey, L., Förster, J., Liffers, S., Schröder, C., Köster, J., Henschel, L., Ludwig, K. U., Laehnemann, D., Trajkovic‐Arsic, M., Behrens, D., et al. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01623-z · Cited by 15
Molecular Pathology of Pancreatic Cystic Lesions with a Focus on Malignant Progression
Hu, Y., Jones, D. M., Esnakula, A. K., Krishna, S. G., & Chen, W. (2024) · Cancers · doi:10.3390/cancers16061183 · Cited by 15
The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment
Li, Y., Zheng, Y., Xu, S., Hu, H. H., Peng, L., Zhu, J., & Wu, M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111944 · Cited by 15
Network-based feature screening with applications to genome data
Wu, M., Zhu, L., & Feng, X. (2018) · The Annals of Applied Statistics · doi:10.1214/17-aoas1097 · Cited by 14
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
Betancourt, L. H., Pawłowski, K., Eriksson, J. O., Szász, A. M., Mitra, S., Plá, I., Welinder, C., Ekedahl, H., Broberg, P., Appelqvist, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41625-z · Cited by 14
Neoplastic–Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer
Honselmann, K. C., Finetti, P., Birnbaum, D. J., Monsalve, C. S., Wellner, U. F., Begg, S. K. S., Nakagawa, A., Hank, T. P., Li, A., Goldsworthy, M. A., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0439 · Cited by 15
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer
Arnold, F., Gout, J., Wiese, H., Weissinger, S. E., Roger, É., Perkhofer, L., Walter, K., Scheible, J., Bozzo, C. P., Lechel, A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2633 · Cited by 15
Analysis of Immune Gene Expression Subtypes Reveals Osteosarcoma Immune Heterogeneity
Wan, B., Wang, R., Nie, J., Sun, Y., Zhang, B., Liu, W., & Chen, D. (2021) · Journal of Oncology · doi:10.1155/2021/6649412 · Cited by 13
Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models
Hoare, O., Fraunhoffer, N. A., Kaoutari, A. E., Gayet, O., Bigonnet, M., Roques, J., Nicolle, R., McGUCKIN, C. P., Forraz, N., Sohier, E., et al. (2021) · Cancers · doi:10.3390/cancers13102473 · Cited by 17
Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer
Hong, J. Y., Cho, H. J., Kim, S. T., Park, Y. S., Shin, S. H., Han, I. W., Lee, J., Heo, J. S., & Park, J. O. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211038478 · Cited by 14
Immunological and clinical immunotherapy implications of NLRP3 mutations in melanoma
Wang, Q., Lyu, J., Zhang, W., Shi, F., Ren, Y., Mao, Q., Liu, Y., Li, Y., & Wang, S. (2021) · Aging · doi:10.18632/aging.203678 · Cited by 14
The Intricate Metabolism of Pancreatic Cancers
Camelo, F. S., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_5 · Cited by 15
Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC
Cattolico, C., Bailey, P., & Barry, S. T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.816517 · Cited by 17
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer
Liu, H., D’Alesio, M., AlMasri, S. S., Hammad, A. Y., DeSilva, A., Lebowitz, S., Rieser, C. J., Ashwat, E., Hampton, E. D., Khachfe, H. H., et al. (2023) · HPB · doi:10.1016/j.hpb.2023.01.016 · Cited by 14
Bioinformatic analysis reveals pancreatic cancer molecular subtypes specific to the tumor and the microenvironment
Large, T. Y. S. L., Prado, M. M., Krell, J., Bijlsma, M. F., Meijer, L. L., Geert Kazemier, M., Frampton, A. E., & Giovannetti, E. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1175940 · Cited by 14
Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
Connor, A. A., & Gallinger, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1324296 · Cited by 14
Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma
Lewis, H. L., Chakedis, J. M., Talbert, E. E., Haverick, E. N., Rajasekera, P. V., Hart, P., Bloomston, M., Dillhoff, M. E., Pawlik, T. M., D, D. C. G., et al. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24940 · Cited by 14
Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset
Ho, J., Li, X., Zhang, L., Liang, Y., Hu, W., Yau, J. C. W., Chan, H., Gin, T., Chan, M. T. V., Tse, G., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.04.004 · Cited by 14
The role of lineage specifiers in pancreatic ductal adenocarcinoma
Camolotto, S. A., Belova, V. K., & Snyder, E. L. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2018.05.04 · Cited by 14
Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities
Wang, Y., Lakoma, A., & Zogopoulos, G. (2020) · Genes · doi:10.3390/genes11091098 · Cited by 14
Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer
Yu, Y., Schuck, K., Frieß, H., & Kong, B. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1857727 · Cited by 16
A Clinically Applicable 24-Protein Model for Classifying Risk Subgroups in Pancreatic Ductal Adenocarcinomas using Multiple Reaction Monitoring-Mass Spectrometry
Son, M., Kim, H., Han, D., Kim, Y., Huh, I., Han, Y., Hong, S., Kwon, W., Kim, H., Jang, J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3513 · Cited by 14
Self-citation
Pancreatic cancer
Roth, S., Apte, M. V., Balachandran, V. P., Biffi, G., Conroy, T., Cukierman, E., Dotan, E., Esposito, I., Grünwald, B. T., Klauß, M., et al. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00699-6 · Cited by 19
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
ten Hoorn, S., Waasdorp, C., van Oijen, M. G. H., Damhofer, H., Trinh, A. C., Zhao, L., Smits, L. J. H., Bootsma, S., van Pelt, G. W., Mesker, W. E., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09436-0 · Cited by 13
Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma
Dong, M., Tang, R., Wang, W., Xu, J., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., Zhang, B., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101692 · Cited by 13
Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer
Grützmeier, S. E., Kovacevic, B., Vilmann, P., Rift, C. V., Melchior, L. C., Holmström, M. O., Brink, L., Hassan, H., Karstensen, J. G., Grossjohann, H., et al. (2023) · Cancers · doi:10.3390/cancers15143677 · Cited by 13
Personalized treatment in localized pancreatic cancer
Neoptolemos, J. P., Hu, K., Bailey, P. J., Springfeld, C., Cai, B., Miao, Y., Michalski, C. W., Carvalho, C. T., Hackert, T., & Büchler, M. W. (2023) · European surgery. Supplement/European surgery · doi:10.1007/s10353-023-00814-x · Cited by 13
Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy
Horvat, N. K., Karpovsky, I., Phillips, M. J., Wyatt, M. M., Hall, M. A., Herting, C. J., Hammons, J., Mahdi, Z. K., Moffitt, R. A., Paulos, C. M., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008086 · Cited by 13
Self-citation
Advancements in Preclinical Models of Pancreatic Cancer
Salu, P., & Reindl, K. M. (2024) · Pancreas · doi:10.1097/mpa.0000000000002277 · Cited by 13
Myofibroblastic cancer‐associated fibroblast subtype heterogeneity in pancreatic cancer
Kearney, J. F., Trembath, H. E., Chan, P., Morrison, A. B., Xu, Y., Luan, C., McCabe, I. C., Zarmer, S., Kim, H. J., Peng, X. L., et al. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.27582 · Cited by 13
Self-citation
Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma
Yuen, J. G., Hwang, G., Fesler, A. T., Intriago, E., Pal, A. S., Ojha, A., & Ju, J. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200769 · Cited by 13
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Szczepanski, J. M., Rudolf, M. A., & Shi, J. (2024) · Cancers · doi:10.3390/cancers16040794 · Cited by 15
Recurrent mutations in tumor suppressor FBXW7 bypass Wnt/β-catenin addiction in cancer
Zhong, Z., & Virshup, D. M. (2024) · Science Advances · doi:10.1126/sciadv.adk1031 · Cited by 14
ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients
Huerta, M., Martín-Arana, J., Gimeno-Valiente, F., Carbonell‐Asins, J. A., García-Micó, B., Martínez-Castedo, B., Robledo-Yagüe, F., Camblor, D. G., Fleitas, T., Bartolomé, M. G., et al. (2024) · Translational research · doi:10.1016/j.trsl.2024.05.003 · Cited by 16
Single-cell analysis defines LGALS1+ fibroblasts that promote proliferation and migration of intrahepatic cholangiocarcinoma
Cao, Q., Yang, J., Jiang, L., Yang, Z., Fan, Z., Chen, S., Zhu, S., Yin, L., Wang, H., & Wen, W. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae023 · Cited by 13
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer
Dimitrieva, S., Harrison, J. M., Chang, J. E., Piquet, M., Mino-Kenudson, M. A., Gabriel, M., Sagar, V., Horn, H., Lage, K., Kim, J., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0489 · Cited by 12
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy
Li, H., Zhang, Z., Shi, Z., Zhou, S., Nie, S., Yu, Y., Zhang, L., Sun, Y., Fang, C., Hu, J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101927 · Cited by 13
Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer
Kawai, M., Fukuda, A., Ikeda, M., Iimori, K., Mizukoshi, K., Iwane, K., Yamakawa, G., Omatsu, M., Namikawa, M., Sono, M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci177533 · Cited by 13
Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of retinoic acid receptor gamma and AKT by mesothelin
Lurie, E., Liu, D., LaPlante, E. L., Thistlethwaite, L. R., Yao, Q., & Milosavljevic, A. (2020) · Oncogenesis · doi:10.1038/s41389-020-00245-3 · Cited by 11
Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma
Naso, J. R., Topham, J. T., Karasinska, J. M., Lee, M. K. C., Kalloger, S. E., Wong, H., Nelson, J., Moore, R. A., Mungall, A. J. J., Jones, S. J. M., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3695 · Cited by 13
Towards Personalized Treatment Strategies for Esophageal Adenocarcinoma; A Review on the Molecular Characterization of Esophageal Adenocarcinoma and Current Research Efforts on Individualized Curative Treatment Regimens
Hoefnagel, S. J. M., Boonstra, J. J., Russchen, M. J. A. M., & Krishnadath, K. K. (2021) · Cancers · doi:10.3390/cancers13194881 · Cited by 13
Antibody-Based Approaches to Target Pancreatic Tumours
Sorbara, M., Cordelier, P., & Béry, N. (2022) · Antibodies · doi:10.3390/antib11030047 · Cited by 15
Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer
Wang, C., Chen, Y., Yin, X., Xu, R., Song, J., Ruze, R., Xu, Q., & Zhao, Y. (2022) · BMC Cancer · doi:10.1186/s12885-022-09927-0 · Cited by 12
Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
Li, Y., Hong, Y. K., Wang, X., Pandit, H., Zheng, Q., Yu, Y., Shi, X., Chen, Y., Tan, M., Pulliam, Z., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1430 · Cited by 14
Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
Zhao, J., Li, Y., Wu, Y., Zhang, K., Peng, L., & Chen, H. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01530-x · Cited by 13
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells
Simbolo, M., Silvestris, N., Malleo, G., Mafficini, A., Maggino, L., Cocomazzi, A., Veghini, L., Mombello, A., Pezzini, F., Sereni, E., et al. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100251 · Cited by 13
Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts
Ruess, D. A., Görgülü, K., Wörmann, S. M., & Algül, H. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0453-y · Cited by 15
Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants
Giri, B., Sethi, V., Dudeja, V., Banerjee, S., Livingstone, A. S., & Saluja, A. K. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000382 · Cited by 13

Authors: Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., Smyla, J. K., Anderson, J. M., Kim, H. J., Bentrem, D. J., Talamonti, M. S., Iacobuzio-Donahue, C. A., Hollingsworth, M. A., & Yeh, J. J.
Affiliations: University of North Carolina at Chapel Hill (US)
University of Nebraska–Lincoln (US)
Northwestern University (US)
Corresponding author: Yeh, Jen Jen
ORCID: Moffitt, Richard A
Marayati, Raoud
Hoadley, Katherine A
Rashid, Naim U
Williams, Lindsay A
Bentrem, David J
Iacobuzio-Donahue, Christine A
Hollingsworth, Michael A
Yeh, Jen Jen
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 2015-09-07
Volume: 47
Issue: 10
Pages: 1168-1178
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng.3398
PMC: PMC4912058
OpenAlex: W1497915798
Cited by: 2,194
References: 63
Citations by year: 2026: 227 · 2025: 237 · 2024: 236 · 2023: 252 · 2022: 256 · 2021: 298 · 2020: 223 · 2019: 168 · 2018: 124 · 2017: 96 · 2016: 65 · 2015: 9
FWCI: 42.80
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (T32CA009156, R01CA140424, P30CA060553)
National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK034897, P30DK034987)
National Institute of Environmental Health Sciences (P30ES010126)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords: pancreatic ductal adenocarcinoma, tumor stroma, tumor subtypes, gene expression signatures, blind source separation, basal-like subtype, prognostic subtypes, metastatic pancreatic cancer, molecular classification
MeSH terms: Adenocarcinoma, Animals, Female, Humans, Male, Pancreatic Neoplasms, Gene Expression, Stromal Cells, Genetic Heterogeneity, Carcinoma, Pancreatic Ductal, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks